Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)
Launched by GADJAH MADA UNIVERSITY · Oct 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people recover from serious heart conditions known as acute coronary syndromes (ACS) by providing rehabilitation at home, with the support of family members. The researchers want to find out if this home-based program, which includes exercise, diet changes, and stress management, is better than regular care in improving the patients' quality of life and physical fitness.
To join the study, participants must be between 18 and 65 years old, have been hospitalized for ACS within the last year, and live with family who can help with their care. They should be in stable physical and mental health, meaning they don’t have serious other health issues and are not showing signs of depression. Over the 12-week program, participants will follow a structured plan that includes walking exercises, dietary changes, and regular check-ins with a doctor. This trial is not yet recruiting, but it aims to empower both patients and their families in the recovery process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with acute coronary syndrome who have undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of interview.
- • 2. Aged 18-65 years, participants were selected with age variations representing young adults, adults and the elderly.
- • 3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not.
- • 4. Patients living with family and family involved in the patient care process.
- • 5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP
- • \>90, systolic \<150 mmhg; N: 60-100x/min; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument.
- • 6. Willing to participate in the study.
- Exclusion Criteria:
- • Patients with comorbidities that require routine medication such as Diabetes Mellitus, hypertension, renal failure
About Gadjah Mada University
Gadjah Mada University, a prestigious institution located in Yogyakarta, Indonesia, is recognized for its commitment to advancing research and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at enhancing medical knowledge and improving patient outcomes. With a focus on ethical standards and scientific integrity, Gadjah Mada University collaborates with healthcare professionals and researchers to ensure that its clinical trials contribute valuable insights to the medical community and support the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sleman, Yogyakarta, Indonesia
Yogyakarta, , Indonesia
Patients applied
Trial Officials
Anggoro Budi Hartopo, PhD
Study Director
Gadjah Mada University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported